lamivudine has been researched along with Acute-On-Chronic Liver Failure in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, YH; Wan, YM; Wu, HM; Wu, XN; Xu, Y; Xu, ZY | 1 |
| Chen, SR; Ke, WM; Lai, J; Lin, CS; Yang, L; Zhang, YQ | 1 |
| Chang, JY; Chen, CH; Chien, RN; Hu, TH; Hung, CH; Lee, CM; Lin, CL; Lu, SN; Tseng, PL; Wang, JH | 1 |
| Shouval, D | 1 |
| Chen, G; Hu, XY; Luo, JX; Wang, YY; Yang, F; Zhang, Y; Zhong, S; Zhou, TY | 1 |
| Hong, R; Lang, X; Li, Z; Xiang-Hui, Y; Xiao-Feng, S; Yan, Z | 1 |
| Gao, H; Li, X; Lin, M; Lin, T; Pan, C; Wang, X; Zhou, R | 1 |
| Yuen, MF | 1 |
| Chen, G; Chen, X; Jiang, D; Yang, G; Yang, J; Zhang, H | 1 |
| Gao, F; Geng, M; Jiang, Y; Li, A; Li, X; Li, Y; Liu, H; Liu, Y; Sun, L; Wang, R; Wang, X; Yang, Z; Ye, X; Zeng, H; Zhang, H; Zhou, G | 1 |
| Huang, KW; Kuan, YC; Luo, JC; Tam, KW | 1 |
2 review(s) available for lamivudine and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Anti-viral therapy in hepatitis B virus reactivation with acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Prognosis | 2015 |
Efficacy and Safety of Lamivudine Versus Entecavir for Treating Chronic Hepatitis B Virus-related Acute Exacerbation and Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis.
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Guanine; Hepatitis B, Chronic; Humans; Lamivudine; Randomized Controlled Trials as Topic | 2017 |
1 trial(s) available for lamivudine and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation.
Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Drug Resistance, Viral; End Stage Liver Disease; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Polymorphism, Restriction Fragment Length; Predictive Value of Tests; Prognosis; Severity of Illness Index | 2014 |
8 other study(ies) available for lamivudine and Acute-On-Chronic Liver Failure
| Article | Year |
|---|---|
Genotype Matters in Patients with Acute-on-chronic Liver Failure Due to Reactivation of Chronic Hepatitis B.
Topics: Acute-On-Chronic Liver Failure; Adult; Aged; Antiviral Agents; DNA, Viral; Female; Follow-Up Studies; Genotype; Guanine; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Prospective Studies; Tenofovir; Viral Load; Virus Activation; Young Adult | 2018 |
Pretreatment HBsAg level and an early decrease in MELD score predict prognosis to lamivudine treatment for HBeAg-negative acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adult; DNA, Viral; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Lamivudine; Male; Middle Aged; Prognosis; Retrospective Studies; Reverse Transcriptase Inhibitors; Severity of Illness Index | 2014 |
The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B.
Topics: Acute-On-Chronic Liver Failure; End Stage Liver Disease; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male | 2014 |
Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adult; Alanine Transaminase; Antiviral Agents; Biomarkers; China; DNA, Viral; Female; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Time Factors; Treatment Outcome; Viral Load; Virus Activation | 2014 |
Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: using virologic response at week 4.
Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Male; Middle Aged; Prognosis; Survival Analysis; Time Factors; Treatment Outcome | 2014 |
[Nucleoside analogues for acute-on-chronic liver failure associated with hepatitis B virus infection: a 24-month survival analysis].
Topics: Acute-On-Chronic Liver Failure; Antiviral Agents; Cohort Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Prospective Studies; Survival Analysis; Survival Rate; Telbivudine; Thymidine; Time Factors | 2015 |
Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.
Topics: Acute-On-Chronic Liver Failure; Adenine; Adolescent; Adult; Aged; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Prognosis; Retrospective Studies; Survival Analysis; Treatment Outcome; Young Adult | 2015 |
Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
Topics: Acute-On-Chronic Liver Failure; Adult; Antiviral Agents; Decision Support Techniques; Drug Resistance, Viral; End Stage Liver Disease; Female; Guanine; Hepatitis B, Chronic; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2017 |